Liver transplantation offers live-saving therapy for patients with complications of cirrhosis
and stage T2 hepatocellular carcinoma. The demand for organs far outstrips the supply, and …

In the past 5 years, important advances have been made in the scientific understanding and
clinical management of cholangiocarcinoma (CCA). The cellular immune landscape of CCA …

Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …

Liver cancers are the fourth leading cause of cancer-related mortality worldwide. In the past
decade, breakthroughs in the field of artificial intelligence (AI) have inspired development of …

Intrahepatic cholangiocarcinoma (iCCA) develops inside the liver, between bile ductules
and the second-order bile ducts. It is the second most frequent primary liver cancer after …

Intrahepatic cholangiocarcinoma (iCCA) has previously been considered a contraindication
to liver transplantation (LT). However, recent series showed favorable outcomes for LT after …

These guidelines for the diagnosis and management of cholangiocarcinoma (CCA) were
commissioned by the British Society of Gastroenterology liver section. The guideline writing …

Cholangiocarcinoma (CCA) represents the second‐most common primary liver malignancy
after HCC and has risen in incidence globally in the past decades. Intrahepatic …

Primary liver cancer (PLC) is a fatal disease that affects millions of lives worldwide. PLC is
the leading cause of cancer-related deaths and the incidence rate is predicted to rise in the …

Intrahepatic cholangiocarcinoma is the second most frequent primary liver cancer after
hepatocellular carcinoma. According to International Classification of Diseases-11 (ICD-11) …